NDC 72934-2094

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%

Hyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.1%

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Hyaluronate Sodium; Tazarotene.

Product ID72934-2094_8838d911-0db3-f66e-e053-2995a90acb53
NDC72934-2094
Product TypeHuman Prescription Drug
Proprietary NameHYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
Generic NameHyaluronic Acid Sodium Salt 0.5% / Tazarotene 0.1%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-07
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameHYALURONATE SODIUM; TAZAROTENE
Active Ingredient Strength1 g/100g; g/100g
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2094-2

30 g in 1 BOTTLE, PUMP (72934-2094-2)
Marketing Start Date2019-05-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2094-2 [72934209402]

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-07

Drug Details

Active Ingredients

IngredientStrength
HYALURONATE SODIUM.5 g/100g

Pharmacological Class

  • Retinoid [EPC]
  • Retinoids [CS]
  • Retinoid [EPC]
  • Retinoids [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.